XENETIC BIOSCIENCES, INC. Increase (Decrease) in Prepaid Expense
XENETIC BIOSCIENCES, INC. (XBIO) reported Increase (Decrease) in Prepaid Expense of $491 for the 3-month period ending 2013-11-30, per its 10-Q filed 2014-01-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2014-01-10
- XENETIC BIOSCIENCES, INC. increase (decrease) in prepaid expense for the quarter ending 2013-11-30 was $491.00.
- XENETIC BIOSCIENCES, INC. increase (decrease) in prepaid expense for the quarter ending 2013-08-31 was -$149.00.
- XENETIC BIOSCIENCES, INC. increase (decrease) in prepaid expense for fiscal 2013 was -$9.22K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month | Increase (Decrease) in Prepaid Expense 22 month |
|---|---|---|---|---|---|
| 2013-11-30 | $491.00 10-Q · filed 2014-01-10 | $342.00 derived: sum of 2 quarters · filed 2014-01-10 | |||
| 2013-08-31 | -$149.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | -$9.22K 10-K · filed 2013-11-27 | |||
| 2013-05-31 | -$9.07K 10-Q · filed 2013-07-17 | -$9.07K 10-Q · filed 2013-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |